Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

ClinicalTrials.gov ID: NCT03948178

Public ClinicalTrials.gov record NCT03948178. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS: Open-Label Extension for Patients Completing Study 3119002

Study identification

NCT ID
NCT03948178
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Orion Corporation, Orion Pharma
Industry
Enrollment
227 participants

Conditions and interventions

Interventions

  • Levosimendan Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 25, 2019
Primary completion
Nov 17, 2020
Completion
Nov 17, 2020
Last update posted
Mar 8, 2023

2019 – 2020

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
26
Facility City State ZIP Site status
Neuromuscular research Centre and Neuromuscular Clinic of Arizona Phoenix Arizona 85028
University of California San Diego La Jolla California 92037-0886
University of California Irvine Medical Center Orange California 92868
Hospital for Special Care New Britain Connecticut 06053
Georgetown University Washington D.C. District of Columbia 20007
The George Washington Medical Faculty Associates Washington D.C. District of Columbia 20037
Holy Cross Hospital Neuroscience Institute Fort Lauderdale Florida 33308
University of Florida McKnight Brain Institute Gainesville Florida 32611
Mayo Clinic Jacksonville Jacksonville Florida 32224
University of South Florida/USF Health Tampa Florida 33612
Augusta University, Medical Centre Augusta Georgia 30912
Northwestern University Feinberg School of Medicine Chicago Illinois 60611
University of Chicago Chicago Illinois 60637
Johns Hopkins Hospital Baltimore Maryland 21287
Massachusetts General Hospital Boston Massachusetts 02114
University of Michigan, Michigan Medicine University Hospital Ann Arbor Michigan 48109
Health Partners Speciality Center Saint Paul Minnesota 55130-5302
Washington University School of Medicine St Louis Missouri 63110
Neurology Associates Lincoln Nebraska 68506
Hospital for Special Surgery New York New York 10021
Columbia Presbyterian Hospital New York New York 10032
Neurosciences Institute - Neurology Charlotte Charlotte North Carolina 28207
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157-1023
The Ohio State University Wexner Medical center Columbus Ohio 43210
Oregon Health and Science University Portland Oregon 97201-3098
Providence Brain and Spine Institute Portland Oregon 97213
Alleghenay General hospital Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Nerve and Muscle Centre of Texas Houston Texas 77030
University of Utah Health-Imaging & Neurosciences Center in research Park Salt Lake City Utah 84132
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03948178, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 8, 2023 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03948178 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →